Extent of the acute phase response in fulminant hepatic failure.
Open Access
- 1 July 1994
- Vol. 35 (7) , 982-986
- https://doi.org/10.1136/gut.35.7.982
Abstract
The extent of the acute phase response and the relation between acute phase proteins and cytokines in plasma was investigated in 50 patients with fulminant hepatic failure. On admission, C reactive protein was significantly higher in fulminant hepatic failure (median: 12.4 micrograms/ml, range:0.2-112 micrograms/ml) than in 20 controls (median: 0.8 microgram/ml, range: 0.3-2.9 micrograms/ml, p < 0.001). Serial measurements showed that plasma C reactive protein increased daily after admission until day 5, the end of the study period. alpha 1-Antitrypsin (AAT) (median: 69.1%, range: 27.5-124%) and fibrinogen (median: 1.10 g/l, range: 0-2.82 g/l) were significantly lower in fulminant hepatic failure on admission than in controls (AAT: median: 126%, range: 75.4-149%; fibrinogen: median 2.48 g/l, range: 1.82-3.39 g/l, p < 0.001) and did not change subsequently. Both AAT and fibrinogen were maintained at significantly higher concentrations in survivors than in those who did not. Bacterial infection occurred in 23 patients during the course of fulminant hepatic failure, but did not influence the concentrations of these three proteins. Interleukin 6 was significantly higher in fulminant hepatic failure (median: 21.2 pg/ml, range: 0-871 pg/ml) than in controls (median: 2.4 pg/ml, range: 1.5-8.2 pg/ml, p < 0.001). There was a significant correlation between interleukin 6 and the C reactive protein concentrations in patients with viral hepatitis on admission and in all patients 48 hours later, consistent with other evidence that interleukin 6 stimulates synthesis of this acute phase protein.Keywords
This publication has 30 references indexed in Scilit:
- Recombinant human interleukin‐6 (IL‐6/BSF‐2/HSF) regulates the synthesis of acute phase proteins in human hepatocytesPublished by Wiley ,2001
- Interleukin‐6 is the major regulator of acute phase protein synthesis in adult human hepatocytesPublished by Wiley ,2001
- Circulating interleukin 6 as a useful marker for predicting postoperative complicationsCytokine, 1992
- Physiological inhibitors of coagulation in fulminant hepatic failureBlood Coagulation & Fibrinolysis, 1992
- Thrombin—antithrombin III complex in fulminant hepatic failure: evidence for disseminated intravascular coagulation and relationship to outcomeEuropean Journal of Clinical Investigation, 1990
- Fate and biological action of human recombinant interleukin 1β in the rat in vivoEuropean Journal of Immunology, 1989
- Changes in rat liver mRNA for alpha-1 acid-glycoprotein, apolipoprotein E, apolipoprotein B and beta-actin after mouse recombinant tumor necrosis factor injectionBiochemical and Biophysical Research Communications, 1989
- Interleukin 6, the third mediator of acute‐phase reaction, modulates hepatic protein synthesis in human and mouse. Comparison with interleukin 1 β and tumor necrosis factor‐αEuropean Journal of Immunology, 1988
- ENHANCED TUMOUR NECROSIS FACTOR AND INTERLEUKIN-1 IN FULMINANT HEPATIC FAILUREThe Lancet, 1988
- Induction of rat acute‐phase proteins by interleukin 6 in vivoEuropean Journal of Immunology, 1988